Carregando...
The art of drug synthesis /
| Outros Autores: | , |
|---|---|
| Formato: | Printed Book |
| Idioma: | English |
| Publicado em: |
Hoboken, N.J. :
Wiley-Interscience,
c2007.
|
| Assuntos: | |
| Acesso em linha: | http://www.loc.gov/catdir/toc/ecip0717/2007017891.html http://www.loc.gov/catdir/enhancements/fy0739/2007017891-b.html http://www.loc.gov/catdir/enhancements/fy0739/2007017891-d.html |
| LEADER | 03150cam a22003734a 4500 | ||
|---|---|---|---|
| 008 | 070427s2007 njua b 001 0 eng | ||
| 010 | |a 2007017891 | ||
| 016 | 7 | |a 101305787 |2 DNLM | |
| 020 | |a 9780471752158 (cloth) | ||
| 020 | |a 0471752150 (cloth) | ||
| 035 | |a (OCoLC)ocn123962939 | ||
| 035 | |a (OCoLC)123962939 | ||
| 042 | |a pcc | ||
| 060 | 1 | 0 | |a QV 744 |b A784 2007 |
| 082 | 0 | 0 | |a 615.19 |2 22 |
| 245 | 0 | 4 | |a The art of drug synthesis / |c edited by Douglas S. Johnson, Jie Jack Li. |
| 260 | |a Hoboken, N.J. : |b Wiley-Interscience, |c c2007. | ||
| 300 | |a xv, 276 p. : |b ill. ; |c 26 cm. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Piñeiro-Núñez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 1 | 2 | |a Drug Design. |
| 650 | 2 | 2 | |a Chemistry, Pharmaceutical |x methods. |
| 700 | 1 | |a Johnson, Douglas S. | |
| 700 | 1 | |a Li, Jie Jack. | |
| 856 | 4 | 1 | |u http://www.loc.gov/catdir/toc/ecip0717/2007017891.html |
| 856 | 4 | 2 | |u http://www.loc.gov/catdir/enhancements/fy0739/2007017891-b.html |
| 856 | 4 | 2 | |u http://www.loc.gov/catdir/enhancements/fy0739/2007017891-d.html |
| 942 | |c BK | ||
| 906 | |a 7 |b cbc |c orignew |d 1 |e ecip |f 20 |g y-gencatlg | ||
| 955 | |a aa27 2007-05-09 |a ps08 2007-08-16 1 copy rec'd., to CIP ver. |a xf04 2009-02-04 copy 2 added | ||
| 999 | |c 95967 |d 95967 | ||
| 952 | |0 0 |1 0 |4 0 |6 615_190000000000000_JOH_A |7 0 |9 95844 |a UL |b UL |c ST1 |d 2011-11-14 |g 0.00 |l 0 |o 615.19 JOH/A |p 86104 |r 2012-10-28 |v 5820.69 |y BK | ||